Atrial fibrillation (AF) is the most common clinically significant arrhythmia. 1 The clinical consequences of AF relate to an increased risk of mortality and morbidity from stroke, heart failure and death. 2 Even short episodes of AF are associated with atrial myocardial damage, expression of prothrombotic factors, activation of platelets and inflammatory cells, collectively contributing to a generalised prothrombotic state and, subsequently, increased risk for clinical events. 3 Several studies have examined the complex and, most likely, multi-faceted aetiology of AF, with a likely central role for inflammation. 4 The presence of a systemic inflammatory, prothrombotic state may also contribute to the higher risk for comorbidities. 5 Interestingly, the presence of cardiovascular risk factors, but also inflammation, has previously been related to the presence of vascular dysfunction. 6 Hence, this review poses that endothelial dysfunction may contribute to